쎌바이오텍 분기보고서 (2017.03)
1. 요약재무정보

가. 요약연결재무정보

구 분	제 23기 1분기	제 22기	제 21기

(2017년3월말)	(2016년12월말)	(2015년12월말)

[유동자산]	59,661,134,984	69,267,535,256	54,150,513,012

·현금및현금성자산	9,723,792,944	10,594,468,521	7,272,875,829

·매출채권및기타유동채권	9,825,599,362	10,792,304,471	9,311,574,554

·금융상품자산	37,002,855,545	45,198,950,000	34,606,184,587

·단기투자자산	-	-

·재고자산	2,422,131,393	2,052,900,092	2,521,478,081

·기타유동자산	686,755,740	628,912,172	438,399,961

[비유동자산]	21,364,584,584	21,261,696,865	20,817,336,026

·장기매출채권및기타비유동채권	341,024,165	342,479,173	264,874,621

·금융상품자산	5,000,000	5,000,000	505,000,000

·장기투자증권	283,975,523	266,592,405	287,043,173

·유형자산	19,393,800,133	19,524,253,609	18,780,486,861

·무형자산	1,135,527,972	939,269,664	843,148,796

·이연법인세자산	205,256,791	184,102,014	136,782,575

자 산 총 계	81,025,719,568	90,529,232,121	74,967,849,038

[유동부채]	5,292,918,050	6,360,902,280	6,163,135,072

[비유동부채]	20,952,000	15,476,000	47,462,020

부 채 총 계	5,313,870,050	6,376,378,280	6,210,597,092

[지배기업 소유주지분]	75,711,849,518	84,152,853,841	68,757,251,946

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(12,921,092,595)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	40,518,228	33,453,542	48,368,033

[이익잉여금]	71,132,669,791	71,920,072,650	56,509,556,264

[비지배지분]	-	-	-

자 본 총 계	75,711,849,518	84,152,853,841	68,757,251,946

기 간	(2017.01.01~	(2016.01.01~	(2015.01.01~

2017.03.31)	2016.12.31)	2015.12.31)

매출액	14,617,904,593	58,275,830,849	49,504,515,603

영업이익	5,646,855,566	21,561,007,533	18,758,807,947

당기순이익	3,458,597,141	18,498,516,386	17,505,140,264

지배기업 소유주지분	3,465,661,827	18,483,601,895	17,505,140,264

비지배지분	-	-	-

주당순이익	451	2,396	2,268

연결에포함된회사수	3	3	3

나.요약별도재무정보

구 분	제 23기 1분기	제 22기	제 21기

(2017년3월말)	(2016년12월말)	(2015년12월말)

[유동자산]	56,202,332,452	68,130,327,104	53,860,925,500

·현금및현금성자산	9,102,191,058	10,048,170,009	6,822,021,385

·매출채권및기타유동채권	10,281,525,166	11,300,441,465	10,418,352,866

·금융상품자산	33,763,521,695	44,298,950,000	33,706,184,587

·단기투자자산	-	-	-

·재고자산	2,372,211,734	1,995,382,673	2,488,101,480

·기타유동자산	682,882,799	487,382,957	426,265,182

[비유동자산]	33,692,945,050	23,717,557,562	22,233,829,427

·장기매출채권및기타비유동채권	37,850,411	37,850,411	8,850,411

·금융상품자산	5,000,000	5,000,000	505,000,000

·장기투자증권	177,342,127	166,528,857	224,009,929

·종속기업투자주식	13,218,445,020	3,218,445,020	2,118,819,740

·유형자산	19,271,772,892	19,386,662,974	18,616,137,994

·무형자산	854,927,968	775,249,663	689,416,428

·이연법인세자산	127,606,632	127,820,637	71,594,925

자 산 총 계	89,895,277,502	91,847,884,666	76,094,754,927

[유동부채]	4,893,419,952	6,216,204,771	5,415,695,302

[비유동부채]	25,952,000	20,476,000	47,677,600

부 채 총 계	4,919,371,952	6,236,680,771	5,463,372,902

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(5,260,426,445)	(5,260,426,445)	(5,260,426,445)

[기타포괄손익누계액]	165,987	(592,760)	(3,298,882)

[이익잉여금]	72,776,411,914	73,412,469,006	58,435,353,258

자 본 총 계	84,975,905,550	85,611,203,895	70,631,382,025

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2017.01.01~	(2016.01.01~	(2015.01.01~

2017.03.31)	2016.12.31)	2015.12.31)

매출액	14,081,487,806	56,495,596,508	49,024,773,708

영업이익	5,817,049,795	21,126,350,787	19,214,527,103

당기순이익	3,609,942,908	18,065,115,748	17,330,744,519

주당순이익	468	2,340	2,245